Vivos Therapeutics (VVOS) Non-Current Deffered Revenue (2022 - 2025)
Vivos Therapeutics (VVOS) recorded Non-Current Deffered Revenue of $1,000 in Q3 2025, down 99.4% from $178,000 a year earlier and down 80.0% from the prior quarter.
Powered by 
Analysis
Vivos Therapeutics (VVOS) Non-Current Deffered Revenue (2022 - 2025) Analysis & Trends
At the end of FY2024, Vivos Therapeutics reported Non-Current Deffered Revenue of $97,000, down 66.4% from FY2023.
- Across earlier years, Non-Current Deffered Revenue came in at $289,000 in FY2023 (+158.0%) and $112,000 in FY2022.
- The Q3 2025 figure is the lowest quarterly Non-Current Deffered Revenue in data going back to Q1 2022.
- On a year-over-year basis, Non-Current Deffered Revenue has declined for five consecutive quarters, with an average decline of 10.2% over the last eight quarters.
- Peak year-over-year performance for Non-Current Deffered Revenue in the last five years was growth of 158.0% in Q4 2023, against a decline of 99.4% in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $5,000 (Q2 2025), $22,000 (Q1 2025) and $97,000 (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 249.71 Bn | 228.86 Bn | 4.88 Bn | - |
| 2 | Abbott Laboratories | 171.00 Bn | 142.08 Bn | 7.27 Bn | - |
| 3 | Danaher | 155.79 Bn | 139.61 Bn | 3.61 Bn | - |
| 4 | Intuitive Surgical | 143.91 Bn | 123.46 Bn | 1.96 Bn | - |
| 5 | Medtronic | 110.42 Bn | 76.29 Bn | 6.34 Bn | - |
| 6 | Stryker | 105.71 Bn | 91.82 Bn | 4.50 Bn | - |
| 7 | Boston Scientific | 63.26 Bn | 58.27 Bn | 3.85 Bn | - |
| 8 | Edwards Lifesciences | 49.80 Bn | 33.91 Bn | 1.35 Bn | - |
| 9 | Becton Dickinson | 48.78 Bn | 45.93 Bn | 2.32 Bn | - |
| 10 | Vivos Therapeutics | 2.18 Mn | -7.03 Mn | 2.95 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 5,000.00 |
| Mar 31, 2025 | 22,000.00 |
| Dec 31, 2024 | 97,000.00 |
| Sep 30, 2024 | 178,000.00 |
| Jun 30, 2024 | 352,000.00 |
| Mar 31, 2024 | 533,000.00 |
| Dec 31, 2023 | 289,000.00 |
| Sep 30, 2023 | 240,000.00 |
| Jun 30, 2023 | 264,000.00 |
| Mar 31, 2023 | 250,000.00 |
| Dec 31, 2022 | 112,000.00 |
| Sep 30, 2022 | 180,000.00 |
| Jun 30, 2022 | 317,000.00 |
| Mar 31, 2022 | 375,000.00 |
API Access
Vivos Therapeutics Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=VVOS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "VVOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=VVOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();